REGULATORY STRATEGIES FOR FILING OF NDA IN ICH COUNTRIES (US, EUROPE and JAPAN)

Abstract

 ABSTRACT Developing new drugs requires great amount of research work in Chemistry, Manufacturing, Controls, preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the responsibility of evaluating whether the research data support the safety, efficacy and quality control of a new drug product to serve the public health. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate the marketing of the drugs. This article focuses on drug approval process in different countries like USA, Europe and Japan. Keywords: MAA, USFDA, Drug approval process, Clinical Trial.

Authors and Affiliations

Priyanka Gangarapu, P. Jayachandra Reddy, M. Alagu Sundaram, M. Sabareesh, V. Prabhakaran

Keywords

Related Articles

 FORMULATION AND EVALUATION OF MICROSPHERES FOR IMMEDIATE AND SUSTAINED RELEASE OF DIFFERENT DRUGS USING SAME POLYMER

 Dosage forms that can precisely control the release rates and target drugs to a specific body site have made an enormous impact in the formulation and development of novel drug delivery systems. Microspheres form...

 TABLETING PROPERTIES OF THERMALLY ACTIVATED COW BONE POWDER IN HIGH DOSE FORMULATION

 ABSTRACT Activated cow bone powder was evaluated and found suitable as a diluent in the formulation of low and high dose drugs. This study was conducted in order to compare the diluent properties of dicalcium pho...

 PHOSPHOLIPON AS A BINDER IN THE FORMULATION OF 4-ACETOMIDOPHENOL TABLETS

 ABSTRACT Pharmaceutical manufacturing inform of liposomal delivery has one of the most important approaches to improve the cellular uptake and subsequent bioavailability of drugs and as such phospholipon was chos...

 AN REVIEW ON (SMEDDS) SELF MICRO-EMULSIFYING DRUG DELIVERY SYSTEM

 ABSTRACT In pharmaceutical solubility is one of the biggest problem to formulate the suitable dosage form because according to new chemical (drug) entities around 40% drug exhibit poor aqueous solubility and low...

 PHYTOCHEMICAL EVALUATION OF A MEDICINAL ORCHID: NERVILIA PLICATA (ANDREWS) SCHLTR

 ABSTRACT The present study on phytochemical constituents of a medicinal orchid such as Nervilia plicata (Andrews) Schltr. reveals that, it is one of the valuable orchid with diverse medico-potentiality. More over...

Download PDF file
  • EP ID EP128354
  • DOI -
  • Views 70
  • Downloads 0

How To Cite

Priyanka Gangarapu, P. Jayachandra Reddy, M. Alagu Sundaram, M. Sabareesh, V. Prabhakaran (2015).  REGULATORY STRATEGIES FOR FILING OF NDA IN ICH COUNTRIES (US, EUROPE and JAPAN). International Journal of Pharmaceutical Development & Technology, 5(2), 101-113. https://europub.co.uk/articles/-A-128354